Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
A/Jax mice were rendered immune to the syngeneic and transplantable methylcholanthrene-induced Sarcoma 1509a by the surgical removal of the tumor 7 days after implantation; subsequent injection i.v. transfer of 10(7) to 10(8) washed thymus or spleen cells of tumor-bearing animals (TBA) to immune animals significantly inhibited the rejection of the tumor; this suppressive effect was entirely abolished by the treatment of these lymphocytes with anti-theta serum or anti-thymocyte serum (ATS) and complement before adoptive transfer. On the other hand, an equal number of thymus or spleen cells of normal animals or of animals bearing an unrelated tumor had no suppressive effect. Treatment of normal syngeneic animals with ATS after tumor cell inoculation or splenectomy of TBA resulted in the suppression of the tumor growth. The serum of TBA had no effect on tumor growth in immune syngeneic mice. Together these results suggest that TBA possess immunosuppressor T cells regulating negatively their immune response to the tumor.
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000494:pharmacology; D006084:Graft Rejection; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D051379:Mice; D008805:Mice, Inbred A; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000276:immunology*; D013156:Splenectomy; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D014185:Transplantation, Isogeneic
D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum